Lab
RR Laboratory Services, INC
RR Laboratory Services, INC was paid $1.10M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 12% of everything it billed.
33Billing provider infoRR LABORATORY SERVICES, INC
HATILLO, PR 00659
HATILLO, PR 00659
33aNPI1427485895assigned 10/01/2013
33bProvider typeClinical Medical Laboratory
28Total paid$1.10M
24GClaims108,605
24DCodes billed54
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#111 of 777
Median peer was paid$278K
This provider vs. median4.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,770 | $93K | |
| 2019 | 8,459 | $64K | |
| 2020 | 9,015 | $74K | |
| 2021 | 18,060 | $202K | |
| 2022 | 19,544 | $246K | |
| 2023 | 21,901 | $219K | |
| 2024incomplete | 19,856 | $206K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 3,266 | 2,985 | $132K |
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 8,455 | 7,941 | $124K |
| 80061 | Lipid panel | 11% | 9,375 | 8,832 | $116K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.1% | 3,825 | 3,586 | $101K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.8% | 14,239 | 13,097 | $97K |
| 80053 | Comprehensive metabolic panel | 7.3% | 8,762 | 8,186 | $81K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.9% | 2,770 | 2,549 | $65K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.3% | 5,314 | 4,974 | $47K |
| 82274 | 3.4% | 2,574 | 2,404 | $38K | |
| 81000 | 3.0% | 11,384 | 10,630 | $33K | |
| 82607 | 2.3% | 1,806 | 1,679 | $25K | |
| 84153 | 2.0% | 1,279 | 1,201 | $22K |
42 more codes
| 36415 | Collection of venous blood by venipuncture | 1.9% | 9,760 | $21K |
| 86738 | 1.8% | 1,559 | $20K | |
| 82043 | 1.7% | 3,415 | $19K | |
| 87276 | 1.2% | 1,064 | $14K | |
| 87088 | 1.2% | 1,769 | $13K | |
| 84479 | 1.2% | 2,291 | $13K | |
| 84436 | 1.2% | 2,135 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 259 | $13K |
| 87275 | 1.2% | 1,048 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 1,486 | $12K |
| 84439 | <1% | 1,085 | $10K | |
| 86701 | <1% | 1,036 | $9K | |
| 82565 | <1% | 1,241 | $5K | |
| 80050 | General health panel | <1% | 444 | $4K |
| 86328 | <1% | 164 | $4K | |
| 82947 | <1% | 1,145 | $4K | |
| 80074 | <1% | 80 | $4K | |
| 87400 | <1% | 365 | $4K | |
| 84520 | <1% | 1,063 | $4K | |
| 86592 | <1% | 799 | $3K | |
| 82746 | <1% | 270 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 94 | $3K |
| 85651 | <1% | 748 | $2K | |
| 82570 | <1% | 422 | $2K | |
| 86803 | <1% | 140 | $2K | |
| 83970 | <1% | 46 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 37 | $1K |
| 86769 | <1% | 29 | $1K | |
| 85730 | <1% | 158 | $841.61 | |
| 85610 | <1% | 211 | $731.79 | |
| 82728 | <1% | 58 | $685.64 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $667.29 |
| 86631 | <1% | 39 | $517.45 | |
| 86140 | <1% | 85 | $371.83 | |
| 86038 | <1% | 29 | $316.87 | |
| 83655 | <1% | 19 | $250.61 | |
| 82378 | <1% | 14 | $249.82 | |
| 84156 | <1% | 55 | $192.46 | |
| 83540 | <1% | 13 | $80.19 | |
| 82950 | <1% | 15 | $58.09 | |
| 82270 | <1% | 16 | $45.30 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 837 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBLES, RIGOBERTO (PRESIDENT)